CMF
FLGT icon

Counterpoint Mutual Funds’s Fulgent Genetics FLGT Stock Holding History

Counterpoint Mutual Funds’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Buy
34,306
+15,056
+78% +$327K 0.08% 167
2025
Q4 		$506K Buy
+19,250
New +$499K 0.04% 111
2023
Q4 		– Sell
-7,257
Closed -$194K – 174
2023
Q3 		$194K Buy
+7,257
New +$248K 0.16% 61
2023
Q2 		– Sell
-6,380
Closed -$199K – 367
2023
Q1 		$199K Buy
6,380
+1,326
+26% +$42.7K 0.17% 32
2022
Q4 		$151K Buy
+5,054
New +$181K 0.16% 94

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return